Editorial
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Diabetes. Oct 15, 2013; 4(5): 170-176
Published online Oct 15, 2013. doi: 10.4239/wjd.v4.i5.170
Chemo-profiling of eucalyptus and study of its hypoglycemic potential
Baishakhi Dey, Analava Mitra
Baishakhi Dey, Analava Mitra, School of Medical Science and Technology, IIT Kharaghpur 721302, India
Author contributions: Dey B and Mitra A developed the basic theme idea jointly; data collection, preparation of the editorial was done by Dey B; Mitra A provided valuable suggestions to develop the work.
Correspondence to: Analava Mitra, MBBS, PhD, School of Medical Science and Technology, IIT Kharaghpur 721302, India. analavamitra@gmail.com
Telephone: +91-94-75258298 Fax: +91-32-22279970
Received: March 6, 2013
Revised: May 17, 2013
Accepted: July 23, 2013
Published online: October 15, 2013
Core Tip

Core tip: Eucalyptuses, indigenous to various countries of the world has been described in various Aboriginal, British and European Pharmacopoeias with its wide range of phytochemicals demonstrating a range of pharmacological effects including hypoglycemic action. The volatile and non-volatile constituents of Eucalyptus include terpenes and tri-terpenoids, flavonoids, flavanols, gallotannins, quercetin, euglobals, procyanidins, macro carpals. Pharmacopoeias have reported uses of hot eucalyptus leaf decoctions as tea to act as hypoglycemic agents. This editorial attempts to assess and highlight eucalyptus species with anti-diabetic potential and the probable biomolecules contributing to this along with their mechanistic role, as well as their posology and safety.